Abstract
The effect of human atrial natriuretic peptide (hANP) on blood pressure (Bp) was evaluated in 11 patients who had elevated systoric Bp of over 150 mmHg during surgery. A bolus injection of 50μg or 100μg of hANP decreased Bp with an immediate response by 27.6±3.1 mmHg (P<0.001) or 40.7±4.2 mmHg (P<0.001), respectively, accompanying with tremendously increased urine output. Heart rate and\(Pa_{O_2 } \) were not altered. Thus, a intravenous bolus injection of hANP is an useful therapeutic tool for the treatment of acutely elevated Bp during anesthesia.
Similar content being viewed by others
References
Laragh JH: Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressureelectrolyte homeostasis. N Engl J Med 313:1330–1340, 1985.
Ackermann U, Irizawa TG, Milojevic S, Sounenberg H: Cardiovascular effects of atrial extracts in anesthetized rats. Can J Physiol Pharmacol 62: 819–826, 1984.
Hirata Y, Ishii M, Sugimoto T, Matsuoka H, Sugimoto T, Kangawa K, Matsuo H: The effects of human atrial 28-amino acid peptide on systemic and renal hemodynamic in anesthetized rats. Circ Res 57: 634–639, 1985.
Iwanaga R, Hori S, Suzuki H, Nakajima S, Saruta T, Kojima S, Fukuda K, Satoh T, Kusuhara M, Handa S, Nakamura Y, Yoshinaga K, Yamaguchi K: Cardiovascular effects of intravenous and intracoronary administration of atrial natriuretic peptide in halothane anesthetized dogs. Life Sci 42: 1279–1286, 1988.
Ishii M, Sugimoto T, Matsuoka H, Ishimitsu T, Atarashi K, Hirata Y, Sugimoto T, Kangawa K, Matsuo H: Hemodynamic, renal and endocrine responses to alphahuman atrial natriuretic polypeptide (α-hANP) in healthy volunteers. Circulation 72: suppl III, 294, 1985.
Weidmann P, Hellmueller B, Vehlinger DE, Lang RE, Gnaedinger MP, Hasler L, Shaw S, Bachmann C: Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man J Clin Endocrinol Metab 62:1027–1036, 1986.
Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A, Pondolfino K, Clark M, Camargo MJF, Scarborough RM, Lewicki JA: Atrial natriuretic factor in normal subjects and heart failure patients. J Clin Invest 78:1362–1374, 1986.
Allen MJ, Gilmour SM, Singer M, Bennett ED: Effects of atrial natriuretic peptide on systemic haemodynamics and cardiac function in normal man. Cardiovasc Res 23:70–75, 1989.
Riegger GAJ, Kromer EP, Kochsiek K: Human atrial natriuretic peptide: Plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure. J Cardiovascul Pharmacol 8:1107–1112, 1986.
Saito H, Ogihara T, Nakamura M, Hara H, Higaki J, Rakugi H, Takeyama H, Minamino T, Iimura K, Kumahara Y: Hemodynamic, renal, and hormonal responses to alpha-human atrial natriuretic peptide in patients with congestive heart failure. Clin Pharmacol Ther 42:142–147, 1987.
Stoelting RK: Autonomic regulation of cardiovascular function. ASA Annual Refresher Course Lecture 1981, 201.
Kopman EA, Weygandt GR, Bauer S, Feruson TB: Arterial hypoxemia following the administration of sublingual nitroglycerine. Am Heart J 96:444–447, 1978.
Casthely PA, Lear S, Cottrell JE, Lear E: Intrapulmonary shunting during induced hypotension. Anesth Analg 61:231–235, 1982
Author information
Authors and Affiliations
About this article
Cite this article
Iwatsuki, N., Katoh, M., Yasuda, A. et al. Effects of intravenously administered human atrial natriuretic peptide on elevated blood pressure during surgery. J Anesth 3, 218–222 (1989). https://doi.org/10.1007/s0054090030218
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s0054090030218